Amyris, inc. reports fourth quarter and full year 2021 financial results

Emeryville, calif., march 1, 2022 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-markettm technology platform, today announced financial results for its fourth quarter and full year ended december 31, 2021.
AMRS Ratings Summary
AMRS Quant Ranking